Publications by authors named "Marta Morotti"

Article Synopsis
  • * NPs can act as carriers for immunomodulatory agents or nucleic acid-based therapies, allowing for better gene expression regulation and immune modulation, as shown in preclinical studies.
  • * Understanding the interaction between NPs and the CNS immune system, particularly the role of the biomolecular corona, is crucial for optimizing NP design to improve their effectiveness and safety in therapeutic applications.
View Article and Find Full Text PDF

Dystrophin is a cytoskeletal protein contributing to the organization of the neuromuscular junction. In Duchenne muscular dystrophy, due to dystrophin absence, the distribution of endplate acetylcholine receptors (AChRs) becomes disorganized. It is still debated whether this is due to the absence of dystrophin or to the repeated damage/regeneration cycles typical of dystrophic muscle.

View Article and Find Full Text PDF

Duchenne muscular dystrophy (DMD) is an X-linked disease, caused by a mutant dystrophin gene, leading to muscle membrane instability, followed by muscle inflammation, infiltration of pro-inflammatory macrophages and fibrosis. The calcium-activated potassium channel type 3.1 (K3.

View Article and Find Full Text PDF

Background And Purpose: Amyotrophic lateral sclerosis (ALS) patients exhibit dysfunctional energy metabolism and weight loss, which is negatively correlated with survival, together with neuroinflammation. However, the possible contribution of neuroinflammation to deregulations of feeding behaviour in ALS has not been studied in detail. We here investigated if microglial K 3.

View Article and Find Full Text PDF

We retrospectively examined the incidence, onset, risk factors, and outcomes of renal injury during 103 treatment courses of liposomal amphotericin B (L-AMB) in 97 adult patients with hematological malignancies. All the patients were analyzed before, during, and after the administration of L-AMB, and renal injury was graded according to the RIFLE criteria (risk, injury, failure, loss of function, end-stage renal disease). Most patients (87.

View Article and Find Full Text PDF